Funding to stop Candida auris lacking

July 16, 2019

Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.

Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.

The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.

A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.

Read the article.

See the latest posts on our homepage


Share

Topic Area: Infection Control


Recent Posts
Recent Posts
Focus: Infection Control

Adopting EVS cleaning practices in skilled nursing facilities


The presence of more higher-acuity patients has led to greater danger from infections

1/20/2020

Focus: Infection Control

Probe: Hospital used OR without HEPA filter when infant got sick


Other operating rooms at the hospital had HEPA filters

1/20/2020

Focus: Infection Control

Chicago-area hospitals using tracking technology to monitor hand hygiene


Healthcare providers only wash or sanitize their hands only about half as much as they should

1/20/2020

Blog

The prescription for a healthy JCAHO audit


A robust, prescriptive EAM system is needed to avoid surprises and support a facility’s ongoing success

1/20/2020

Focus: HVAC

Planning and budgeting key to sustainable HVAC


Step one in achieving sustainable HVAC design is organizational buy-in

1/20/2020





Post Comment




FREE
NEWSLETTER

News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.